Broadfin Capital, LLC, 10% Owner at Mirati Therapeutics, Inc. (MRTX), sold 60,000 shares at $18.05 ($1.1M) on 2017-11-16, disclosed to the SEC on 2017-11-20.
Open-market sale of $1.1M MRTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BDSI | SELL | 2019-05-14 | $9.0M | — | Filing → |
| REPH | SELL | 2018-05-24 | $1.1M | — | Filing → |
| REPH | SELL | 2018-03-15 | $2.0M | — | Filing → |